Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 11, 2024JAMA Internal Medicine

Opioid Prescribing and Outcomes in Patients With Sickle Cell Disease Post–2016 CDC Guideline

View Full Paper
Ask AI
Bookmark
Share

Authors

HKHyeun Ah KangBWBofei WangJBJamie C. Barner

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kang et al. (2024) studied this question.

synapsesocial.com/papers/68e74801b6db6435876c14bchttps://doi.org/10.1001/jamainternmed.2023.8538
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 16699 Sickle cell disease: managing acute painful episodes in hospital2024 · 6 citations
  2. 2Conducting Interrupted Time-series Analysis for Single- and Multiple-group Comparisons2015 · 1,301 citations
  3. 3Rates of Physician Coprescribing of Opioids and Benzodiazepines After the Release of the Centers for Disease Control and Prevention Guidelines in 20162019 · 61 citations
  4. 4CDC Clinical Practice Guideline for Prescribing Opioids for Pain<b>—</b>United States, 20222022 · 1,835 citations
  5. 5Trends in Opioid Use Among Cancer Patients in the United States: 2013-20182021 · 25 citations